Consistency in infringement cases with an average of ten filings per month LONDON, July 10, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today launched the report One year later in the UPC: First insights from Dartsip™, which analyzes litigation data from the Unitary Patent Court's (UPC) inaugural year. The analysis sheds light on the future direction of the UPC and its continued role alongside the European national courts and other major global ...

New report highlights challenges and opportunities in resilient MedTech industry LONDON, July 2, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the release of the MedTech Trends to Watch 2024 report, the second installment in a two-part series offering a predictive analysis of emerging trends shaping the MedTech industry. Highlighting both challenges—such as economic uncertainty, regulatory shifts and fragile supply chains—and oppor ...

Core Insights - The report by Clarivate Plc highlights the rapid growth and societal benefits of digital health, emphasizing the integration of various data sources to analyze the evolving landscape of healthcare technology [1][5][6]. Research Impact - The digital health revolution is marked by significant increases in research and patent activity, identifying key global players and emerging companies in the field [5][10]. - The study combines data from the Web of Science and Derwent World Patents Index to provide a comprehensive analysis of digital health, categorized into major fields [5][10]. Growth in Digital Health - There has been a nearly 70-fold increase in academic papers mentioning digital health from 2012 to 2022, driven by advancements in artificial intelligence and analytics [10]. - Patent activity in digital health has surged, with approximately 140,000 patent inventions recorded from 2013 to 2022, indicating strong industry efforts to secure intellectual property [10]. Corporate Dynamics - The patent analysis reveals a diverse mix of organizations involved in digital health, showcasing collaborations between companies like Snap and AstraZeneca, and Nike and Johnson & Johnson [10]. - Mainland China plays a crucial role in AI patenting within digital health, with significant contributions from the Chinese Academy of Sciences and various universities and corporations [10]. Influence of Academic Research - University research is pivotal in driving digital health innovation, with research papers often cited in patents, underscoring their impact on intellectual property advancements [10].

The IP Collaboration Hub enables users to save time and reduce risks in the IP filing and prosecution process by providing a portal for instructors and local agents to collaborate and exchange information, while automatically docketing everything in the IPMS. This portal addresses a critical issue in the IP industry – over-reliance on email for communication – which introduces risk into the process. The Hub automates and standardizes communication management between law firms, corporations and their local a ...

LONDON, June 20, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released the 2024 update to the Journal Citation Reports™ (JCR™). The reports provide an essential and comprehensive resource of high-quality journals, ranked by field to enable academic institutions, researchers and publishers to gauge the significance of journals in the global research landscape. Changes to journal rankings include the addition of the Emerging Sources Citation I ...

Major pharmaceutical companies are eager to partner with or acquire ADC developers to enhance their oncology pipelines. ADCs combine a cytotoxic payload, a monoclonal antibody (mAb), and a chemical linker, offering greater target specificity and a wider therapeutic index than traditional therapies, delivering toxic agents directly to cancer cells while sparing healthy tissues. specific antigens in ovarian, lung, and other solid tumors, aiming to provide safer and more effective treatment options. Clarivate ...

Insights from the new InCites Benchmarking & Analytics module support strategic investment and demonstrate impact About Clarivate Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com Media contact: Rebecca Krahenbuhl, Senior Manager, External Communications, Aca ...

Strategic collaboration enhances insight into patient demographics and behaviors, enabling analytical precision in addressing population health outcomes LONDON, May 31, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a strategic partnership with HealthWise Data, a leading healthcare data and analytics firm bridging the gap between clinical outcomes and Social Determinants of Health (SDoH) domains. The collaboration integrates SDoH att ...

LONDON, May 30, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT; CLVT PR A) ("Clarivate"), a leading global provider of transformative intelligence, announced today that its 5.25% Series A Mandatory Convertible Preferred Shares (the "Preferred Shares"), will automatically and mandatorily convert into ordinary shares of Clarivate on June 3, 2024 (the "Conversion Date"). The mandatory conversion rate for each Preferred Share will be 3.8462 ordinary shares of Clarivate. Cash will be paid in lieu of fractional o ...

LONDON, May 30, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT; CLVT PR A) ("Clarivate"), a leading global provider of transformative intelligence, announced today that its 5.25% Series A Mandatory Convertible Preferred Shares (the "Preferred Shares"), will automatically and mandatorily convert into ordinary shares of Clarivate on June 3, 2024 (the "Conversion Date"). The mandatory conversion rate for each Preferred Share will be 3.8462 ordinary shares of Clarivate. Cash will be paid in lieu of fractional o ...